Evidence map›Paper›PMID 22241105›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2012

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.

Claire Julian-Reynier, Roxane Fabre, Isabelle Coupier, Dominique Stoppa-Lyonnet, Christine Lasset, Olivier Caron, Emmanuelle Mouret-Fourme, Pascaline Berthet, Laurence Faivre, Marc Frenay and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Disclosure of research results: a randomized study on GENEPSO-PS cohort participants.Health expectations : an international journal of public participation in health care and health policy · 2016
    Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Breast cancer in the young: role of the geneticist.Journal of thoracic disease · 2013
    Article
  16. Preimplantation Genetic Testing for Breast Cancer.Nigerian medical journal : journal of the Nigeria Medical Association
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 14 institutions in 2 countries.

Claire Julian-ReynierINSERM, U912, Marseille, France. claire.julian-reynier@inserm.fr
Roxane Fabre
Isabelle Coupier
Dominique Stoppa-Lyonnet
Christine Lasset
Olivier Caron
Emmanuelle Mouret-Fourme
Pascaline Berthet
Laurence Faivre
Marc Frenay
Paul Gesta
Laurence Gladieff
Anne-Deborah Bouhnik
Christel Protière
Catherine Noguès
Aix-Marseille Université · FRCentre Antoine Lacassagne · FRCentre François Baclesse · FRCentre Hospitalier de Niort · FRCentre Hospitalier Universitaire de Montpellier · FRDélégation Paris 5 · FRDélégation Provence et Corse · FRHôpital d'Enfants · FRHôpital René Huguenin · FRInstitut Claudius Regaud · FRInstitut Curie · FRInstitut de Recherche pour le Développement · FRInstitut Gustave Roussy · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the impact of BRCA1/2 test results on carriers' reproductive decision-making and the factors determining their theoretical intentions about preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND).

methodsUnaffected BRCA1/2 mutation carriers of childbearing age (N = 605; 449 women; 151 men) were included at least 1 year after the disclosure of their test results in a cross-sectional survey nested in a national cohort. Multivariate adjustment was performed on the data obtained in self-administered questionnaires.

resultsResponse rate was 81.0%. Overall, 32.5% and 50% said that they would undergo PGD/PND, respectively, at a theoretical next pregnancy, whereas only 12.1% found termination of pregnancy (TOP) acceptable. Theoretical intentions toward PGD did not depend on gender/age, but were higher among those with no future childbearing plans (adjusted odds ratio (AOR) 95% confidence interval (CI): 3.5 (1.9-6.4)) and those having fewer relatives with cancer (AOR 1.5 95% CI (1.0-2.3)). Greater TOP acceptability was observed among males and those with lower educational levels; 85.4% of respondents agreed that information about PGD/PND should be systematically delivered with the test results.

conclusionsThe closer to reproductive decision-making BRCA1/2 carriers are, i.e., when they are more likely to be making future reproductive plans, the less frequently they intend to have PGD. Carriers' theoretical intentions toward PND are discussed further.

Indexed as

HeterozygoteAdolescentAdultAgedBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsCohort StudiesDecision MakingFemaleFranceGenetic Predisposition to DiseaseGenetic TestingHealth Services Needs and DemandHumansMaleBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Identifiers

PMID22241105
PMCPMC4088944
OpenAlexW2089192431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.